International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-5 doi: 10.5281/zenodo.8373627
Original Article
A Descriptive Study on Benign Ductal Disorders of Breast
 ,
 ,
Published
Sept. 22, 2023
Abstract

Background: There are not much information available about benign breast problems like duct ectasia (DE) and periductal mastitis (PDM) even among surgeons and general physicians. The current study aimed to analyse clinical features, procedures as well as surgical modalities associated with these benign breast problems for better understanding of the disease progression and treatment

Methodology: This is a prospective study with sample size of 42 patients conducted in M S Ramaiah teaching hospital, Bangalore conducted between October 2020 to September 2022.

Results: In this study, patients  presented with nipple discharge, breast lump, itching over nipple areolar complex, nipple retraction and breast pain were included. Based upon the symptoms, appropriate investigations like USG, Mammography, FNAC, Cytology of nipple discharge and MRI breast was done. Patients were diagnosed with, Duct ectasia, Duct papilloma, Periductal mastitis and Pituitary adenoma. Appropriate treatment like wide local excision, Microdochectomy, Hadfield’s procedure, conservative treatment were given. A correlation between symptoms, diagnosis and management was done to analyse BBDDs.

Conclusion: Ductal diseases are considered as benign breast problems with unknown etiology. Nipple discharge, breast lump and breast abscess are some of the most common symptoms associated with these problems. In most of these BBDDs conservative management has been proved as the appropriate modality of treatment. With an appropriate guide to diagnosis and management, most ductal diseases can be treated accurately.

Recommended Articles
Loading Image...
Volume-4, Issue-5
Citations
244 Views
38 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved